

Many value investors have given up on their strategy over the last 15 years amid concerns that value investing no longer worked. However, some made small adjustments to their strategy but remained value investors to the core. Now all of the value investors who held fast to their investment philosophy are being rewarded as value Read More
Baylor study highlights promise of IBM’s Watson
Statement from IBM
“In the life sciences industry at large, researchers typically come across one of these target proteins per year,” elaborated IBM Watson VP John Gordon. “Baylor working with Watson found six targets, and the first two that they’ve taken into wet labs have been validated, so they’re outpacing the industry.”
Gordon spoke to Information earlier this week in a phone interview. “People are already finding correlations among disparate sets of data, but because Watson can understand concepts and interpret the direction of research, it can uncover relationships that are more subtle,”
“Even if I’m reading five papers a day, it could take me nearly 38 years to completely understand all of the research already available today on this protein,” explained Dr. Olivier Lichtarge, professor of molecular and human genetics at Baylor, in today’s statement from IBM. “Watson has demonstrated the potential to accelerate the rate and the quality of breakthrough discoveries.”
Updated on